Financials

  • Market Capitalization 376.13 M
  • Employee 55
  • Founded 2012
  • CEO N/A
  • Website www.ateapharma.com
  • Headquarter Massachusetts, United States
  • FIGI BBG00TZNCJ75
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-1.84
ratio cours/chiffre d'affaires

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
3133
ENTA
Enanta Pharmaceuticals, Inc. - Common Stock
13.11 USD-3.89%-6.76%+14.60%+98.94%381.22 M USD
3138
XFOR
X4 Pharmaceuticals, Inc. - Common Stock
4.02 USD-0.74%+3.88%-1.95%+35.35%379.17 M USD
3174
LXEO
Lexeo Therapeutics, Inc. - Common Stock
4.62 USD-0.65%-3.95%-2.12%+11.06%362.77 M USD
3196
VNDA
Vanda Pharmaceuticals Inc. - Common Stock
5.85 USD-2.50%-8.59%-0.51%+5.79%351.79 M USD

Nouvelles